kallikrein信息详情
n.[生化]激肽释放酶；血管舒缓素
kallima inachus───卡利马伊纳胡斯
kallima lnachus───亲爱的伊纳库斯
We studied the mechanism of plasma and tissue kallikrein in activating plasminogen.───作者研究了血浆和组织激肽释放酶激活纤溶酶原的机制。
KBP may playa role in the regulation of metabolism of tissue kallikrein on the level of biosynthesis and excretion.───KBP可能在合成和分泌的水平上，对组织激肽释放酶的代谢及活性起调节作用。
Objective:To explore the possibility of the simultaneous extraction of urokinase and kallikrein.───目的：探讨尿激酶及激肽释放酶同时提取的可能性。
Through the preliminary optimization of the purification condition, we got high purity of pancreas kallikrein product.───通过纯化条件的初步优化，最终得到胰K纯品，收率大于85%。
A second drug, Kallikrein, for stroke prevention, may also be exported.───第二种用于防治中风的药物舒血管素（Kallikrein）也可能出口。
Here, immunocytochemistry was used at both the light- and electron-microscopic levels to localise kallikrein antigenicity.───在这里，用免疫细胞化学在轻型和电镜水平本地化激肽释放酶的抗原性。
On the cell of expressing human tissue kallikrein for gene modification, rigid envelope material with bi-directional flowability is coated.───在基因修饰的表达人组织激肽释放酶的细胞上包覆着具有刚性和双向流通性的包膜材料；
abstract: Objective To observe the clinical efficacy and safety of urinary kallikrein on acute cerebral infarction.───目的探讨尤瑞克林对急性脑梗死的临床疗效及安全性。
Kallikrein is a kind of endopeptidase.
To develop recombinant human pancreatic kallikrein and lay a foundation of hypertension.
The experiment showed that kallikrein in the mother solution in which elastase had been removed by SP resin could be prepared.
Aim: To investigate the expression of human kallikrein 15(KLK15) in the primary epithelial ovarian carcinoma and the clinical significance.
The kallikrein system, which produces the potent vasodilator bradykinin, is beginning to be studied.
The present invention relates to human tissue kallikrein, and is especially the microcapsulized cell of human tissue kallikrein and its microcapsulizing method and application.
The human tissue kallikrein is a subgroup of serine proteinase family wich contains 15 genes.
CONCLUSION Human urinary kallikrein is effective and relatively safe in treatment of acute cerebral infarction in the vascular distribution of the internal carotid artery.
We studied the mechanism of plasma and tissue kallikrein in activating plasminogen.